GB1220201A - Organic compounds based upon benzoxazocines and intermediates and processes therefor - Google Patents

Organic compounds based upon benzoxazocines and intermediates and processes therefor

Info

Publication number
GB1220201A
GB1220201A GB665269A GB665269A GB1220201A GB 1220201 A GB1220201 A GB 1220201A GB 665269 A GB665269 A GB 665269A GB 665269 A GB665269 A GB 665269A GB 1220201 A GB1220201 A GB 1220201A
Authority
GB
United Kingdom
Prior art keywords
benzoxazocines
intermediates
group
organic compounds
compounds based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB665269A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB470D priority Critical patent/GB1220202A/en
Publication of GB1220201A publication Critical patent/GB1220201A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Abstract

1,220,201. Benzoxazocine derivatives. BEECHAM GROUP Ltd. 7 Feb., 1969 [23 Feb., 1968], No. 6652/69. Heading C2C. Novel compounds I (in which R 1 is H or 1-6 C alkyl, R 2 is H, acyl or optionally substituted hydrocarbyl, R 3 is H or an optionally substituted aliphatic or araliphatic hydrocarbyl group and X is H, OH or esterified or etherified OH) their N-oxides and acid addition salts are prepared by treating a compound II with a strong acid, followed, where necessary, by modification of group R 2 by known methods. Pharmaceutical compositions comprise a compound I in association with a suitable carrier or diluent and may be administered orally or parenterally as analgesics.
GB665269A 1968-02-23 1969-02-07 Organic compounds based upon benzoxazocines and intermediates and processes therefor Expired GB1220201A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB470D GB1220202A (en) 1968-02-23 1969-02-07 Pyridine derivatives and intermediates and processes therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70744868A 1968-02-23 1968-02-23

Publications (1)

Publication Number Publication Date
GB1220201A true GB1220201A (en) 1971-01-20

Family

ID=24841740

Family Applications (1)

Application Number Title Priority Date Filing Date
GB665269A Expired GB1220201A (en) 1968-02-23 1969-02-07 Organic compounds based upon benzoxazocines and intermediates and processes therefor

Country Status (10)

Country Link
AT (3) AT296321B (en)
BE (1) BE728790A (en)
BR (1) BR6906543D0 (en)
CH (1) CH525228A (en)
DE (1) DE1908324A1 (en)
ES (1) ES363954A1 (en)
FR (1) FR2002482A1 (en)
GB (1) GB1220201A (en)
NL (1) NL6902802A (en)
SE (1) SE346319B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180669A (en) * 1976-12-13 1979-12-25 Abbott Laboratories 2-(N-phenethyl-4-piperidino)-5-pentyl resorcinol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180669A (en) * 1976-12-13 1979-12-25 Abbott Laboratories 2-(N-phenethyl-4-piperidino)-5-pentyl resorcinol

Also Published As

Publication number Publication date
AT296309B (en) 1972-02-10
DE1908324A1 (en) 1969-09-11
CH525228A (en) 1972-07-15
NL6902802A (en) 1969-08-26
AT296321B (en) 1972-02-10
SE346319B (en) 1972-07-03
FR2002482A1 (en) 1969-10-17
BE728790A (en) 1969-08-01
ES363954A1 (en) 1971-01-01
BR6906543D0 (en) 1973-04-19
AT296308B (en) 1972-02-10

Similar Documents

Publication Publication Date Title
GB1200886A (en) Phenylaminoethanol derivatives
GB1503581A (en) Process for the manufacture of 7-beta-amino-cephem-3-ol-4-carboxylic acid compounds
GB1315608A (en) Pyrimidine carboxylic acids
GB1301973A (en)
GB1250971A (en)
GB1220201A (en) Organic compounds based upon benzoxazocines and intermediates and processes therefor
GB1432503A (en) Cycloalkylalkylesters and process for their preparation
GB1352245A (en) Azabicyclo-3.3.1-nonan-3-ol ester derivatives
GB1292410A (en) Thienobenzothiazepine derivatives
GB1488224A (en) 7alpha-methoxycephalosporin compounds
GB1169027A (en) Azetidine Derivatives
GB1203538A (en) Cubane derivatives
GB1347598A (en) Lincomycin derivatives and the manufacture thereof
GB894460A (en) Improvements in or relating to penicillins
GB1429861A (en) Vincamine derivatives
GB1219387A (en) Bicyclo[2.2.2]oct-2-ene-amino acid compounds
GB1348259A (en) Process for the preparation of 10-oxo-7,10-dihydro-1h-dioxino- 5,4-f-quinolyl-9-carboxylic acids
GB1472257A (en) Derivative of 4-hydroxy-5-azacoumarin
GB1451181A (en) 2-deoxy-2-nicotinamido-1-o-nicotinoylglucopyranose derivatives methods for their preparation and compositions containgin them
GB1397697A (en) Phenoxyalicyclic carboxylic acid derivatives methods of making them and compositions containing them
GB1489784A (en) Pharmaceutically active substituted keto-acid derivatives
GB1398564A (en) 1-amino substituted-1-cycloalkane derivatives of 6-amino penicillanic acid
GB1243767A (en) Isoxazolidine derivatives and their method of preparation
GB1355689A (en) Piperidylfuranones
GB1430188A (en) Diaza-oxa-bicyclodecane derivatives

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees